pamidronate and thyroxine

pamidronate has been researched along with thyroxine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bauss, F; Bosies, E; Fleisch, H; Janner, M; Mühlbauer, RC; Schenk, R; Strein, K1
Chen, V; Ferguson, L; Garber, J; Greenspan, SL; Lee, K; Lee, SL; Moses, AC; Rosen, HN; Ross, DS1
Garber, J; Greenspan, SL; Lee, SL; Moses, AC; Rosen, HN; Ross, DS1
Gomez-Acotto, C; Mautalen, C; Zeni, S1

Reviews

1 review(s) available for pamidronate and thyroxine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for pamidronate and thyroxine

ArticleYear
Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:7

    Topics: Adult; Analysis of Variance; Antineoplastic Agents; Bone Density; Depression, Chemical; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pamidronate; Thyroid Neoplasms; Thyroxine

1998
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
    Calcified tissue international, 1998, Volume: 63, Issue:5

    Topics: Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Biomarkers; Bone and Bones; Bone Resorption; Carcinoma, Papillary; Collagen; Collagen Type I; Creatinine; Diphosphonates; Double-Blind Method; Fasting; Humans; Osteocalcin; Osteolysis; Pamidronate; Peptides; Thyroid Neoplasms; Thyroxine

1998

Other Studies

2 other study(ies) available for pamidronate and thyroxine

ArticleYear
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1991, Volume: 6, Issue:9

    Topics: Alendronate; Animals; Benzoates; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Ibandronic Acid; Injections, Intravenous; Osteoclasts; Pamidronate; Rats; Retinoids; Risedronic Acid; Spectrophotometry, Atomic; Tetracycline; Thyroxine

1991
Do different aminobisphosphonates have similar preventive effect on experimental thyroid hormone-induced osteopenia in rats?
    Calcified tissue international, 2001, Volume: 69, Issue:5

    Topics: Alendronate; Animals; Body Weight; Bone Diseases, Metabolic; Diphosphonates; Female; Pamidronate; Rats; Rats, Sprague-Dawley; Thyroxine

2001